Table 6 The demographics and clinical characteristics in death and survived patients and factor associated with death
Variable (n, %) | All (n = 231) | Univariate analyses | Multivariate analysesa | |||
|---|---|---|---|---|---|---|
Death (n = 38) | Survived (n = 193) | p-value | Adjusted Odd ratio (95% confidence interval) | p-value | ||
Underlying disease | 183, 79.2% | 35, 92.1% | 148, 76.7% | .030 | 1.01 (0.23–4.51) | 0. 981 |
End staged renal disease | 12, 5.2% | 5, 13.2% | 7, 3.6% | .031 | 3.53 (0.91–13.73) | 0.069 |
Hypertension | 110, 47.6% | 26, 68.4% | 84, 43.5% | .007 | 2.63 (1.12–5.86) | 0.047 |
Axial joint involvement | 61, 26.4% | 5, 13.2% | 56, 29.0% | .045 | 0.45 (0.16–1.32) | 0.156 |
Concomitant infection | 57, 24.7% | 15, 39.5% | 42, 21.8% | .025 | 1.57 (0.67–3.69) | 0.343 |
Positive synovial fluid culture | 155, 67.1% | 33, 86.8% | 122, 63.2% | 0.004 | 5.67 (1.94–16.58) | 0.002 |
Positive hemoculture | 157, 68.0% | 30, 80.0% | 127, 65.8% | 0.130 | 2.95 (1.18–7.38) | 0.020 |
Group B streptococcus | 87, 37.7% | 5, 5.7% | 82, 94.3% | < 0.001 | 0.21 (0.07–0.59) | 0.003 |
Staphylococcus aureus | 54, 23.4% | 17, 31.5% | 37, 68.5% | 0.001 | 1.34 (0.55–3.29) | 0.515 |